ACC CardiaCast

This episode is part of ACC's ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Join Drs. Pam Morris and Roger Blumenthal as they explore updates to the Dyslipidemia Guidelines, the patient populations who benefit most, and how to make sense of all of this new information. They provide a practical, evidence‑based discussion designed to support better decision‑making in everyday care.

This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment online course, supported by Merck & Co. and Eli Lilly and Company. Visit the online course to access additional educational activities on this topic.

This episode is part of ACC's ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis. Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis. The conversation highlights symptom variability, sex-based and demographic differences, and screening gaps in the real-world practice.

This podcast is part of the ACC's Transforming Aortic Stenosis Care: An Optimal Approach to Screening & Diagnosis initiative, supported by an educational grant from Edwards Lifesciences.

This episode is part of ACC's ongoing initiative on implementing the 2026 Dyslipidemia guidelines. Join Drs. Samuel Kim and Romit Bhattacharya as they review new therapeutic developments from the guidelines during this discussion on the intersections of dyslipidemia and cardiometabolic syndrome management.

This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment initiative, supported by Merck & Co, and Eli Lilly and Company.

This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG). Drs. Michael Miller and Archna Bajaj discuss the importance of correctly diagnosing sHTG, recognizing familial chylomicronemia syndrome (FCS), and following guideline‑based testing sequences.

This podcast is part of the ACC's Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management initiative, supported by Ionis Pharmaceuticals.

In this CardiaCast episode, Kevin M. Alexander, MD is joined by Sarah Cuddy, MBBCh, to discuss the latest clinical data for investigational therapies and available treatments for transthyretin amyloid cardiomyopathy (ATTR-CM), as well as the potential implications of these findings on clinical practice and future clinical studies. First, they will explore results from CARDIO-TTRansform, the phase 3 trial of eplontersen in ATTR-CM, followed by the results from REVEAL, the phase 3 trial using radiotracer I-124 evuzamitide to detect cardiac amyloidosis. Next, they will discuss findings from ATTRibute-CM and its open-label extension on the survival benefits of acoramidis in variant ATTR-CM (ATTRv-CM) over 54 months. Lastly, they will cover recently published studies describing the extracardiac effects of available therapies for ATTR-CM, specifically those describing the effects of acoramidis on kidney function and the effects of vutrisiran on gastrointestinal events.

This activity is supported by an educational grant from BridgeBio and developed by Med-IQ in collaboration with the American College of Cardiology.

This episode of CardiaCast will feature a discussion on risk assessment and genetics in the prevention of cardiovascular disease.

This podcast is supported by Esperion, Merck, and Novartis.

This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.

This podcast is supported by Esperion, Merck, and Novartis.

In this final episode of the Increasing Role of UACR in Cardiovascular Care series, Drs. Ankeet Bhatt and Brendan Neuen will break down why UACR screening is one of the most powerful yet underused tools for identifying early cardiovascular risk. Together, they examine the latest evidence on therapies and lifestyle strategies that reduce albuminuria, discuss their impact on kidney and cardiovascular risk, and highlight practical considerations for integrating these approaches into everyday clinical care. This podcast is supported by a grant from Boehringer Ingelheim. Visit the course page to learn more about the role of UACR in Cardiovascular Care.

The second episode of the Increasing Role of UACR in Cardiovascular Care series focuses on the most recent evidence-based guidelines for elevated UACR and related cardiovascular (CV) conditions. Dr. Ankeet Bhatt interviews Dr. Nihar Desai on key terminology for albuminuria and discuss CV conditions associated with UACR as a biomarker.

This podcast is supported by a grant from Boehringer Ingelheim. Visit the course page to learn more about the role of UACR in Cardiovascular Care.

This episode of CardiaCast will feature a discussion on the treatment of atherosclerotic cardiovascular disease (ASCVD) risk – from lifestyle to advanced therapies, led by Dr. Maya Safarova. The conversation covers lifestyle "therapy", the treatment algorithm for primary and secondary prevention, and what's on the horizon for ASCVD.

This podcast is supported by Esperion, Merck, and Novartis.

In this first episode of The Increasing Role of Urine Albumin-Creatinine Ratio (UACR) in Cardiovascular Care series, Dr. Ankeet Bhatt interviews Dr. Katherine Tuttle on UACR, its role in kidney disease, and the importance of screening. Listen to Dr. Tuttle provide an overview of the most recent evidence-based practices for UACR screening in cardiovascular disease risk assessment.

This podcast is supported by a grant from Boehringer Ingelheim. Visit the course page to learn more about the role of UACR in cardiovascular care.

This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG). Drs. Michael Miller and Monica Aggarwal review and emphasize the need to understand the multifactorial and genetic causes of HTG and sHTG, as well as the associated risks of pancreatitis and ASCVD.

This podcast is part of the ACC's Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management initiative, supported by Ionis Pharmaceuticals.

This episode is part of ACC's ongoing educational initiative to enhance the recognition, diagnosis, and management of paroxysmal supraventricular tachycardia (PSVT). Faculty review contemporary acute treatment approaches, including established therapies, recent advances, and first-line emergency department strategies with attention to efficacy and safety. The discussion also addresses management of refractory or recurrent cases, decision-making across diverse patient populations and care settings, and criteria for hospital admission versus discharge. Additionally, it provides practical guidance on patient education, symptom recognition, and selecting treatments that balance effectiveness, safety, convenience, and patient confidence.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more.

This episode provides a team-based overview of diagnosing and managing acute paroxysmal supraventricular tachycardia (PSVT) across care settings. It emphasizes how patients interact with providers from primary care to electrophysiology and the importance of coordinated roles. The discussion highlights shared decision-making and targeted education to help patients recognize symptoms, understand recurrence risk, and respond to episodes. Key topics include when to seek care, initial self-management steps, and long-term options such as medication, ablation, or observation. It also reviews practical action plans and the role of newer therapies like intranasal etripamil in individualized care.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more: https://learn.acc.org/Page/LearnSVT

This episode is part of ACC's ongoing initiative to advance education on remote hemodynamic monitoring in heart failure management. Drs. Vishal Rao and Sandip Zalawadiya, along with Ms. Lisa Rathman, CRNP, discuss patient cases highlighting both successful pulmonary artery (PA) pressure device implantation and associated complications. They emphasize key practical considerations, including device placement, patient selection, waveform accuracy, troubleshooting, and team coordination during the procedure.

This podcast is part of the ACC's Pulmonary Artery Pressure Monitoring: Transforming HF Patient Care initiative, supported by Abbott.

This episode is part of ACC's ongoing effort to improve recognition and diagnosis of arrhythmias in clinical practice. In this CardiaCast, faculty explore a modern approach to identifying paroxysmal supraventricular tachycardia (PSVT), with a focus on real-world diagnostic challenges. The discussion highlights how to differentiate PSVT from other common causes of palpitations, interpret normal electrocardiograms between episodes, and recognize patterns that may be misattributed to anxiety, particularly in otherwise healthy patients. The episode also reviews practical strategies for rhythm capture, including ambulatory monitoring and patient-directed documentation, to support timely and accurate diagnosis.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more: https://learn.acc.org/Page/LearnSVT

In this episode, hosts Rosy Thachil, MD, FACC, and Shashank Sinha, MD, FACC, are joined by Jacob Jentzer, MD, FACC, and Ami Bhatt, MD, FACC, Chief Innovation Officer of the American College of Cardiology, for an engaging discussion on AI in the CICU: Transforming Cardiac Critical Care. The conversation explores how artificial intelligence (AI) is beginning to reshape cardiac critical care—from improving clinical decision support and hemodynamic monitoring to predict patient deterioration and optimizing CICU workflows. The panel also discusses the opportunities and challenges of integrating AI into everyday practice and what the future may hold for clinicians caring for the sickest cardiovascular patients.

This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for currently available disease-modifying therapies. Expert faculty Drs. Sarah Cuddy and Prem Soman break down how emerging evidence is reshaping treatment selection, including considerations for efficacy, safety, and patient-specific factors. The discussion highlights practical strategies for integrating these new findings into real-world clinical practice to optimize outcomes for patients with ATTR-CM.

This podcast is developed by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bridge Bio.

In this episode of CardiaCast, Dr. Michael Blaha will be joined by Dr. Ann Marie Navar to discuss the 2026 updates to ACC/AHA guideline on management of dyslipidemia and key clinical trial data supporting the use of PCSK9 inhibitors in getting patients to their lipid goals. They discuss available PCSK9 inhibitors, including the recently approved injectable PCSK9 inhibitor lerodalcibep-liga. After discussing the limitations and barriers associated with injectable PCSK9 inhibitors, they will introduce the emerging oral PCSK9 inhibitors and explore the latest clinical data for enlicitide and AZD0780.

This podcast was developed by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Merck.

This episode is part of ACC's ongoing initiative to advance education on remote hemodynamic monitoring in heart failure management. Drs. Michael Zile, JoAnn Lindenfeld, and William Abraham explore the core capabilities of these devices and how emerging innovations aim to address current limitations. The conversation highlights how clinicians can interpret pressure data and define optimal targets, incorporates the growing role of direct-to-patient communication, and concludes with practical strategies for integrating device-generated insights into clinical workflows to improve patient outcomes.

This podcast is part of the ACC's Pulmonary Artery Pressure Monitoring: Transforming HF Patient Care initiative, supported by Abbott.

In this episode, Drs. Christie Ballantyne and Eugenia Gianos discuss updates regarding the management of dyslipidemia released in new guidelines from the ACC and AHA Joint Committee on Clinical Practical Guidelines. Drs. Ballantyne and Gianos highlight the risks associated with high LDL-C levels and recent developments in clinical guidelines for patients who meet specific criteria for diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) and heterozygous familial hypercholesterolemia (HeFH). Up-to-date therapies are explored in depth.

To visit the course page for the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment, click here!

In this episode, Drs. Ahmad Masri and Kevin Alexander review emerging clinical data in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at the Heart Failure Society of America Annual Scientific Meeting and the American Heart Association Scientific Sessions 2025, including key findings from the ATTRibute-CM and HELIOS-B trials. The discussion highlights recent publications evaluating currently available disease-modifying therapies. Drs. Masri and Alexander translate these new data into practical insights for clinicians, focusing on how evolving evidence may influence treatment selection, therapeutic sequencing, and integration of disease-modifying therapies into everyday clinical practice.

In this episode, Gregory Piazza, MD, FACC, Elvira Grandone, MD, PhD, and Abbey R. Kruper, PsyD, ABPP walk through the clinical and emotional challenges of the link between thrombosis and fertility. They discuss how clotting disorders can influence infertility, what this means for future thrombotic and cardiovascular risk, and how to support patients who are already managing significant stress. The faculty also outlines practical guidance for counseling patients who have experienced thrombosis during pregnancy or assisted reproductive therapy and who want to continue growing their families.

In this episode, Drs. Christie Ballantyne and Anne Goldberg discuss updates on familial hypercholesterolemia (FH) diagnosis and management. Recent publications in January 2026 in the Journal of Clinical Lipidology and The Journal of Pediatrics address refined diagnostic criteria and special populations including children and pregnant women. In this podcast episode, Drs. Ballantyne and Goldberg discuss the importance of early detection, genetic testing, and treatment.

To visit the course page for the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment, click here!

In this podcast, Drs. Michelle Kittleson and Jan Griffin provide a practical overview of evaluation and management of transthyretin amyloid cardiomyopathy (ATTR-CM) based on ACC's 2025 Concise Clinical Guidance document the Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance. The experts elaborate on key takeaways, including identifying cardiac and extra-cardiac features that raise suspicion, outlining the diagnostic pathway and screening strategies, and utilizing current disease-modifying therapies and heart failure management. Guidance on monitoring, determining treatment candidacy, and emerging future therapies is also discussed.

This podcast is supported by an educational grant from BridgeBio.

ACC Chief Innovation Officer Dr. Ami Bhatt brings together Drs. Alexandre Almorad and Christopher Porterfield to discuss how advancements in pulsed field ablation (PFA) are transforming atrial fibrillation treatment. In this episode, the participants break down the latest research in PFA and explain what that means for the procedure's safety and effectiveness.

This podcast is supported by Johnson & Johnson.

Subscribe to CardiaCast

In this episode, Prateeti Khazanie, MD, MPH, discusses common approaches to managing heart failure (HF) patients with chronic kidney disease (CKD), as well as why increased creatinine (Cr) levels should not delay HF treatment.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

"Heart Vision" is a CardiaCast podcast series stemming from the ACC Cardiovascular Imaging Section Leadership Council. This series explores emerging multimodality imaging data, evolving practice trends, disease insights, and advocacy efforts shaping the field of cardiovascular imaging.

In this episode, Dr. Purvi Parwani talks with Drs. Ron Blankstein and Lauren Baldassarre about the new 2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging. They discuss why the document was needed, how it emphasizes competency-based learning, the evolving role of multimodality advanced imaging, and practical takeaways for trainees, educators, and clinicians shaping the future of the field.

Subscribe to CardiaCast

In this episode, Alison Bailey, MD, FACC, and Melvin R. Echols, MD, FACC, discuss current pharmacological and nonpharmacological interventions to prevent and/or decrease the progression of heart failure (HF).

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed at exploring innovations shaping care delivery.

In this episode, Drs. Rupal O'Quinn and Leon Ptaszek join ACC Chief Innovation Officer Dr. Ami Bhatt to delve into the role of consumer wearables in cardiovascular care. They explore scenarios where consumer wearables can provide meaningful value and offer practical tips to help patients effectively share and use their wearable data to manage their health. They also highlight ways clinicians can integrate this information into care conversations to support better outcomes.

Subscribe to CardiaCast |

In this episode, Alison Bailey, MD, FACC, and Melvin R. Echols, MD, FACC, discuss how to incorporate meaningful lifestyle modifications to prevent and/or decrease the prevention of heart failure (HF).

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

This episode is part of ACC's ongoing initiative to advance heart failure (HF) care through team-based collaboration and patient-centered decision-making. Drs. Marty Tam, Lindsey Aurora, Leslie Davis, and Supriya Shore discuss individualized care strategies for patients with HF, with an emphasis on device-based therapies. The conversation kicks off with foundational HF treatments, briefly covers advanced options such as left ventricular assist device and heart transplant, and concludes with a review of established and emerging device therapies for patients who remain symptomatic but are not candidates for advanced interventions.

This podcast is part of the ACC's Beyond the Pill: Advancing Heart Failure Care with Monitoring and Device Therapy initiative, supported by CVRx, Abbott, and Edwards Lifesciences.

Subscribe to CardiaCast |

Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed at exploring innovations shaping care delivery.

In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by Drs. Sunil Rao and David Morrow to discuss the new acute coronary syndrome (ACS) guidelines released earlier this year. They highlight the new recommendations and the real-world evidence behind the new changes. The discussion also addresses how ACS affects different subgroups and how digital health and artificial intelligence can guide ACS care delivery.

Suggested Materials

Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025;85(22):2135-2237. doi:10.1016/j.jacc.2024.11.009

Subscribe to CardiaCast |

In this episode, George G. Sokos, DO, FACC, discusses heart failure (HF) challenges and strategies for prevention in rural and underserved communities.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

"Heart Vision" is a CardiaCast podcast series stemming from the ACC Cardiovascular Imaging Section Leadership Council. This series explores emerging multimodality imaging data, evolving practice trends, disease insights, and advocacy efforts shaping the field of cardiovascular imaging.

In this episode of Heart Vision, Dr. Purvi Parwani sits down with Dr. Rebecca T. Hahn, a leading expert in valvular heart disease and advanced cardiovascular imaging. Together, they discuss the recently released "10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway." Their conversation dives into why this document marks a turning point for tricuspid regurgitation management, the evolving role of multimodality imaging in quantification and procedural planning, and how clinicians can integrate these advances into everyday care.

In this episode, Keith C. Ferdinand, MD, FACC, discusses why low blood pressure (BP) should not delay heart failure (HF) treatment.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed at exploring innovations shaping care delivery.

In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt and Dr. Sanket Dhruva explore how wearables are shaping the future of personalized care. They discuss how wearables impact clinical workflows and clinician-patient relationships and highlight key considerations for clinicians when supporting patients.

ACC Innovation Program

AI Resource Center

Leveraging Apple Watch for Cardiovascular Care

Subscribe to CardiaCast

PulseCheck is a special series within CardiaCast, created specifically for Cardiovascular (CV) Team members. It offers practical, team-based solutions to everyday challenges faced in the field. In this edition, the CV Team Section collaborates with the Cardio-Obstetrics Section to present a five-part series centered on cardio-obstetrics. In this episode, Andrea Price, MS, FACC hosts Kismet Rasmusson, DNP, FNP-BC, and Malamo Countouris, MD, MS, FACC to focus on improving cardio-ob access.

Suggested Materials:

Rasmusson K, Poll J, May, H, et al. Abstract 4125940: Hypertensive Disorders During Pregnancy: Patient Perspectives on Care, Barriers, and a Path Forward. Circulation 2024;150:1. doi:10.1161/circ.150.suppl_1.4125940

Countouris M, Mahmoud Z, Cohen JB, et al. Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care. Circulation. 2025;151(7):490-507. doi:10.1161/CIRCULATIONAHA.124.073302

Watch sessions from Cardio-Obstetrics Essentials 2025, available on-demand on ACC Anywhere. Log in or subscribe to ACC Anywhere to watch the full video series and thousands of other videos from cardiology's top meetings!

Subscribe to CardiaCast |

In this episode, Biykem Bozkurt, MD, PhD, FACC, and Javed Butler, MBBS, MPH, MBA, FACC, discuss best practices incorporating magnetic resonance angiography (MRA) into the heart failure (HF) treatment armamentarium.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

In this special episode of Conversations with Critical Care Cardiologists, host Dr. Carlos Alviar sits down with Drs. Andrea Elliott and Venu Menon to explore how innovative learning formats are shaping the future of critical care cardiology (CCC). You'll hear about simulation-based education at ACC.25, including hands-on training opportunities for physicians and advanced practice providers, and creative teaching methods like a cardiogenic shock escape room and "TED Talk–style" debates that blend humor with high-impact science.

The discussion also dives into the evolution of CCC training, mentorship, and competencies—highlighting insights from the updated AHA statement and recent JACC expert panel. Whether you're a fellow-in-training or a seasoned clinician, this episode offers a fresh look at how the field is redefining how we learn, teach, and grow in acute cardiovascular care.

Subscribe to CardiaCast |

PulseCheck is a special series within CardiaCast, created specifically for Cardiovascular (CV) Team members. It offers practical, team-based solutions to everyday challenges faced in the field. In this edition, the CV Team Section collaborates with the Cardio-Obstetrics Section to present a five-part series centered on cardio-obstetrics. In this episode, Andrea Price, MS, FACC hosts Annia Thomas, MSN, FNP-BC and Jennifer Lewey, MD, MPH, FACC to focus on improving cardio-ob access.

Watch sessions from Cardio-Obstetrics Essentials 2025, available on-demand on ACC Anywhere. Log in or subscribe to ACC Anywhere to watch the full video series and thousands of other videos from cardiology's top meetings!

Subscribe to CardiaCast |

In this episode, Selma F. Mohammed, MBBS, FACC, and Justin M. Vader, MD, FACC, discuss the underlying pathophysiology, signs, and symptoms of heart failure (HF) genotypes, as well as emerging management strategies.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

In this episode, Carol Patrick, DNP, Ron Blankstein, MD, FACC, and Kelley Branch, MD, FACC, explore how coronary computed tomography angiography (CCTA) fits into the clinical decision-making process for evaluating stable chest pain, as outlined in the latest 2021 Chest Pain Guidelines. They break down key insights and practical takeaways for choosing the right diagnostic approach. Tune in to discover how these strategies apply to your practice.

This podcast is part of the larger Modern CCTA Practice: Core Competencies and Advanced Technologies grant initiative, supported by Heartflow. To visit the Modern CCTA Practice webpage and access additional educational activities on this topic, click here.

Subscribe to CardiaCast | Claim CME Credit

ulseCheck is a special series within CardiaCast, created specifically for Cardiovascular (CV) Team members. It offers practical, team-based solutions to everyday challenges faced in the field. In this edition, the CV Team Section collaborates with the Cardio-Obstetrics Section to present a five-part series centered on cardio-obstetrics. In this episode, Andrea Price, MS, AACC hosts Malissa Wood, MD, FACC and Christina Luberto, PhD to focus on maternal mental health.

Suggested Materials:

Pregnancy and Maternal Health Resources and Tools (Go Red For Women website). 2025. Available at: https://www.goredforwomen.org/en/know-your-risk/pregnancy-and-maternal-health/resources-and-tools. Accessed 10/20/25.

Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes (Go Red For Women website). 2025. Available at: https://professional.heart.org/en/science-news/opportunities-in-the-postpartum-period-to-reduce-cv-disease-risk-after-adverse-pregnancy-outcomes. Accessed 10/20/25.

The Role of Cardiovascular Health in Maternal Health (American Heart Association website). 2025. Available at: https://education.heart.org/productdetails/the-role-cardiovascular-health-in-maternal-health. Accessed 10/20/25.

Preeclampsia and High Blood Pressure During Pregnancy (American College of Obstetricians & Gynecologists website). 2025. Available at: https://www.acog.org/womens-health/faqs/preeclampsia-and-high-blood-pressure-during-pregnancy. Accessed 10/20/25.

What's the Concern About High Blood Pressure During Pregnancy? An Ob-Gyn Explains. (American College of Obstetricians & Gynecologists website). 2025. Available at: https://www.acog.org/womens-health/experts-and-stories/the-latest/whats-the-concern-about-high-blood-pressure-during-pregnancy-an-ob-gyn-explains. Accessed 10/20/25.

National Maternal Mental Health Hotline (Health Resources & Services Administration Maternal & Child Health website). 2025. Available at: https://mchb.hrsa.gov/programs-impact/national-maternal-mental-health-hotline. Accessed 10/20/25.

Postpartum Support International website: https://postpartum.net/

Subscribe to CardiaCast | ​ ​

In this episode, Clyde W. Yancy, MD, MSc, MACC, and Leslie L. Davis, NP, PhD, FACC, discuss the 2022 AHA/ACC/HFSA Guideline for the Management of HF and where to consider newer treatments with guideline-directed medical therapy.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed to explore innovations shaping care delivery.

In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt explores the application of artificial intelligence (AI) in electrocardiogram (ECG) with Drs. Demilade Adedinsewo and Ambarish Pandey. The group also discusses how to responsibly implement technology such as the AI-enabled ECG into clinical practice and how to ensure it reduces disparities.

This podcast is supported by Anumana.

Subscribe to CardiaCast |

In this episode, host Dr. Saraschandra Vallabhajosyula is joined by colleagues Drs. Uzoma Ibebuogu, Michael Young, and Dean Boudoulas for a dynamic discussion on the frontline management of pulmonary embolism (PE). Together, they explore evaluation and risk stratification, the role of imaging, catheter-based and surgical treatment strategies, and the importance of systems of care, long-term outcomes, and follow-up. Designed as a conversation among peers, this episode brings practical insights and diverse perspectives on how clinicians can optimize PE care in real-world practice.

Related References

Patel S, Thulasidasan N, Thomson B, et al. Interventional therapies in acute pulmonary embolus-current trends and future directions. Br J Radiol. 2023;96(1149):20221151. doi:10.1259/bjr.20221151

O'Sullivan G, Müller-Hülsbeck S, Haage P, et al. The Central Role of the Interventional Radiologist in Advanced Therapies for Pulmonary Embolism: Results from An Online Member Survey by the Cardiovascular and Interventional Radiological Society of Europe. Cardiovasc Intervent Radiol. 2025;48(6):851-856.

McKeown LA. Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows. 2024. Available at https://www.tctmd.com/news/women-black-patients-less-likely-get-advanced-pe-therapy-analysis-shows. Accessed 10/4/25.

Keeling B, Lookstein RA, Secemsky EA, West FM. Ask The Experts: What Does PE Intervention Look Like in 2034? 2024. Available at https://evtoday.com/articles/2024-july/ask-the-experts-what-does-pe-intervention-look-like-in-2034. Accessed 10/4/25.

Subscribe to CardiaCast |

In this episode, Clyde W. Yancy, MD, MSc, MACC, and Leslie L. Davis, NP, PhD, FACC, discuss the 2023 ACC Expert Consensus Decision Pathway on Management of Patients with HFpEF, and where to consider newer treatments with guideline-directed medical therapy.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

In this episode, Barbara Srichai-Parsia, MD, FACC, Ron Blankstein, MD, FACC and Roosha Parikh, MD, FACC, will focus on the value of fractional flow reserve – computed tomography (FFR-CT) and emerging technologies in streamlining clinical workflow and improving diagnosis. Learners will hear tips on when FFR-CT is most useful, its limitations in specific patient populations, and how artificial intelligence (AI) advances in coronary computed tomography angiography (CCTA) could shape care for patients and clinicians. Practical, evidence-based insights for anyone using cardiac imaging.

This podcast is part of the larger Modern CCTA Practice: Core Competencies and Advanced Technologies grant initiative, supported by Heartflow. To visit the Modern CCTA Practice webpage and access additional educational activities on this topic, click here.

Subscribe to CardiaCast |

PulseCheck is a special series within CardiaCast, created specifically for Cardiovascular (CV) Team members. It offers practical, team-based solutions to everyday challenges faced in the field. In this edition, the CV Team Section collaborates with the Cardio-Obstetrics Section to present a five-part series centered on cardio-obstetrics. In this episode, Andrea Price, MS, AACC hosts Natasha Wolfe, MD and Shantelle Bartra APRN, AACC to focus on pregnancy with congenital heart disease.

Subscribe to CardiaCast |

In this episode, Michelle M. Kittleson, MD, PhD, FACC, and Estefania Oliveros Soles, MD, MSc, FACC, discuss the biggest challenges in heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), focusing on hyperkalemia (uncommon) and hypokalemia (associated with higher mortality).

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. This episode is Part 2 of CV Care of the Masters Athlete where Dr. Jonathan Kim continues the discussion with Drs. Eugene H. Chung, Ankit B. Shah, and Jeffrey J. Hsu on the cardiovascular (CV) care of the masters athlete.

Subscribe to CardiaCast |

PulseCheck is a special series within CardiaCast, created specifically for Cardiovascular (CV) Team members. It offers practical, team-based solutions to everyday challenges faced in the field. In this edition, the CV Team Section collaborates with the Cardio-Obstetrics Section to present a five-part series centered on cardio-obstetrics. In this episode, Andrea Price, MS, AACC hosts Andrea M. Russo, MD, FACC and Erin Ferranti, PhD, MPH, RN to introduce the field of cardio-obstetrics and its importance to listeners.

Subscribe to CardiaCast |

In this episode, Vanessa Blumer, MD, FACC, and Ersilia M. DeFilippis, MD, FACC, discuss the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction (HFrEF). Learners will hear guidance on how to implement a structured multidisciplinary HF approach that improves clinical and patient-centered outcomes.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

In this episode, Michelle M. Kittleson, MD, PhD, FACC, and Estefania Oliveros Soles, MD, MSc, FACC discuss challenges in heart failure (HF) care, focusing on utilization of guideline-directed medical therapy (GDMT). Learners will hear tips on how to add and maximize GDMT in patients with HF.

This podcast is part of the larger Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment grant initiative, supported by Bayer AG. To visit the Managing HF Across the Spectrum page and access additional educational activities on this topic, click here.

Subscribe to CardiaCast

Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed to explore innovations shaping care delivery.

In this episode with Drs. Francisco Lopez-Jimenez and Paul Friedman, ACC Chief Innovation Officer Dr. Ami Bhatt explores the rapid rise of artificial intelligence (AI) tools in cardiovascular care, highlighting why screening tools such as the electrocardiogram (ECG) are particularly well-suited for innovation. The discussion also covers strategies for evaluating AI solutions and best practices for integrating them into clinical workflows.

This podcast is supported by Anumana.

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan H. Kim is joined by Drs. Eugene H. Chung, Ankit B. Shah, and Jeffrey J. Hsu to discuss the cardiovascular care of the masters athlete.

Subscribe to CardiaCast |

Innovation in Action is a podcast series hosted by the ACC Innovation Program aimed to explore innovations shaping care delivery.

In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by ACC Vice President Drs. Roxana Mehran and Carolyn Lam to discuss thrombotic conditions and the importance of addressing gaps in treatment. The conversation also highlights current treatments and recent research exploring novel treatments.

This podcast is supported by Johnson & Johnson.

Subscribe to CardiaCast | Claim CME Credit

Straight from ACC.25, this episode dives into the latest science shaping the care of patients in shock. Join Drs. Shashank Sinha, Ann Gage, Anthony Carnicelli, and David Berg—leading voices in critical care cardiology—as they break down the Altshock-2 study, explore updates from the 2025 ACS Guidelines, and highlight key takeaways from the newly released 2025 ACC Shock Guidance. Whether you're managing patients in the cardiac intensive care unit or leading your heart team through complex cases, this high-yield discussion offers sharp insights, clinical pearls, and evidence you can apply today.

Subscribe to CardiaCast | Claim CME Credit

In this inaugural episode of the new podcast series produced by ACC's Interventional Member Section, Dr. Poonam Velagapudi is joined by featured guests Drs. Debabrata Dash and Thomas Cuisset to discuss the Highlights from EuroPCR 2025.

Explore key insights from the 4D-ACS trial, followed by a discussion on its practical impact in clinical settings. The discussants examine the FAITAVI trial, highlighting major findings and their influence on procedural decision-making. A recent meta-analysis is also reviewed, with commentary on how the collective evidence may shape real-world interventional strategies. Tune in for a dynamic exchange on cutting-edge trials and their implications for the cath lab.

Related References:

The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data (PCR Online). 2025. Available at: https://www.pcronline.com/News/PCR-Press-Releases/2025/EuroPCR-2025-The-FAITAVI-trial-angiography-versus-physiology-guided-PCI-in-patients-undergoing-TAVI-12-month-follow-up-data. Accessed 6/24/25.

Ribichini F, Pesarini G, Fabris T, et al. A randomised multicentre study of angiography- versus physiologyguided percutaneous coronary intervention in patients with coronary artery disease undergoing TAVI: design and rationale of the FAITAVI trial. EuroIntervention. 2024 Apr 15;20(8):e504-e510. doi: 10.4244/EIJ-D-23-00679.

Jang Y, Park SD, Lee JP, et al. One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial. EuroIntervention. 2025 May 21:EIJ-D-25-00331. doi: 10.4244/EIJ-D-25-00331.

Subscribe to CardiaCast | Claim CME Credit

In this episode of CardiaCast, Drs. Erin Michos and Joseph Saseen discuss the underuse of lipid-lowering therapies in patients with cardiovascular risk, despite strong evidence and updated guidelines. They highlight the role of bempedoic acid as a non-statin option, especially for statin-intolerant patients. The conversation emphasizes team-based care, shared decision-making, and strategies to navigate insurance barriers to improve LDL-C management.

This podcast is part of Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscapegrant initiative.

Educational grant support is provided by Esperion.

Related References

Nelson A, Haynes K, Shambhu S, et al. High-intensity statin use among patients with atherosclerosis in the U.S. J Am Coll Cardiol. 2022;79(18):1802–1813. doi:10.1016/j.jacc.2022.02.048

Cannon CP, de Lemos JA, Rosenson RS, et al. Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US. JAMA Cardiol. 2021;6(9):1060–1068. doi:10.1001/jamacardio.2021.1810

Worledge EA, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. Published online April 11, 2025. doi:10.1016/j.jacl.2025.04.186

Subscribe to CardiaCast

In this episode Drs. Poonam Velagapudi, Saraschandra Vallabhajosyula, and James Hermiller explore the critical topic of occupational safety in the cath lab. While healthcare providers focus on treating patients, their work environment can put their own health at risk—particularly long-term impact of wearing heavy lead protection. Drawing from discussions at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Think Tank Sessions, the episode highlights data on lead-free and reduced-lead solutions aimed at preventing back pain and injury among cardiac catheterization operators. Tune in for a timely conversation on protecting the well-being of the heart team.

Related References

Strepkos D, Rempakos A, Alexandrou M, et al. How to Improve Radiation Protection in Interventional Cardiology Procedures. Circ Cardiovasc Interv. 2025;18(4):e014808. doi:10.1161/CIRCINTERVENTIONS.124.014808

Women in Innovations (WIN) Radiation Safety (SCAI website). 2025. Available at: https://scai.org/membership/career-development/women-innovations-win/win-radiation-safety . Accessed 06/17/25.

SCAI Highlights Cath Lab Radiation and Orthopaedic Hazards (Cardiovascular News website). Available at: https://cardiovascularnews.com/scai-highlights-cath-lab-radiation-and-orthopaedic-hazards/. Accessed 06/17/25.

Occupational Health Hazards in the Cardiac Catheterization Laboratory (SCAI website). 2025. Available at: https://scai.org/occupational-health-hazards-cardiac-catheterization-laboratory . Accessed 06/17/25.

Subscribe to CardiaCast | Claim CME Credit

In this episode, Drs. Jenna Skowronski, Francesco Castagna and Saraschandra Vallabhajosyula unpack how assumptions drawn from ST-segment elevation myocardial infarction (STEMI) data may be leading us astray in broader shock management—and what that means for patient outcomes, clinical decision-making, and future research. Why do we keep applying STEMI solutions to non-STEMI problems? Are we oversimplifying cardiogenic shock? And what does the real-world data actually tell us?

Join us for a candid, fast-paced conversation that challenges dogma, calls for nuance, and might just change the way you approach shock.

Related References:

Møller JE, Engstrøm T, Jensen LO, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med. 2024;390(15):1382-1393. doi:10.1056/NEJMoa2312572.

Kochar A, Vallabhajosyula S, John K, et al. Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group. J Heart Lung Transplant. 2024;43(11):1846-1856. doi:10.1016/j.healun.2024.06.012.

Subscribe to CardiaCast | Claim CME Credit

n this episode, Drs. Brittany Weber and Michael Garshick discuss "Pharmacologic Interventions to Lower hs-CRP." This podcast is part of the Inflammation in Cardiovascular Health: Raising Awareness of the Increasing Role of hs-CRP grant initiative.

Educational support for this initiative is provided by Novo Nordisk.

Click here to learn more.

Related References:

Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838-1847.

Ridker PM. From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents? Circulation. 2020;141(10):787-789.

Ridker PM. From RESCUE to ZEUS: Will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? Cardiovasc Res. 2021;117(11):e138-e140.

Ridker PM, Bhatt DL, Pradhan AD, et al; PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401(10384):1293-1301.

Ridker PM, Moorthy MV, Cook NR, et al. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med. 2024;391(22):2087-2097.

Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497-2505.

Subscribe to CardiaCast

In this episode, Drs. Purvi Parwani and Sharonne Hayes discuss "Cardiovascular Health Throughout a Woman's Lifecycle." This podcast is part of the Monitoring Blood Pressure Throughout a Woman's Lifecycle grant initiative.

Educational support for this initiative is provided by Omron.

To visit the course page for the Monitoring Blood Pressure Throughout a Woman's Lifecycle grant, click here.

Suggested Materials

El Khoudary SR, Aggarwal B, Beckie TM, et al; American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation. 2020;142(25):e506-e532.

Lau ES, Michos ED. Blood Pressure Trajectories Through the Menopause Transition: Different Paths, Same Journey. Circ Res. 2022;130(3):323-325.

Samargandy S, Matthews KA, Brooks MM, et al. Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter? Circ Res. 2022;130(3):312-322.

Shimbo D, Artinian NT, Basile JN, et al; American Heart Association and the American Medical Association. Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42-e63.

Wenger NK, Arnold A, Bairey Merz CN, et al. Hypertension Across a Woman's Life Cycle. J Am Coll Cardiol. 2018 Apr 24;71(16):1797-1813.

Wenger NK, Ferdinand KC, Bairey Merz CN, et al. Women, hypertension, and the systolic blood pressure intervention trial. Am J Med. 2016;129:1030-36.

Subscribe to CardiaCast

"Heart Vision" is a CardiaCast podcast series stemming from the ACC Cardiovascular Imaging Section Leadership Council. This podcast series will tackle topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort.

In this episode of Heart Vision, Dr. Purvi Parwani sits down with Dr. Ana Barac, a global leader in cardio-oncology and advanced cardiovascular imaging. Together, they explore the evolving role of imaging in cancer care, the challenges of clinical integration, and how imagers can carve out a meaningful presence in this rapidly growing field. This conversation offers both practical insights and visionary thinking for anyone at the intersection of heart and cancer care.

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Rachel Lampert, Dermot Phelan, and Keri Schafer to continue the discussion on the recently released 2025 Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.

Subscribe to CardiaCast |

In this episode, Drs. Brittany Weber and Paul Ridker discuss "The What, Who, When, and Why of hs-CRP." This podcast is part of the Inflammation in Cardiovascular Health: Raising Awareness of the Increasing Role of hs-CRP grant initiative.

Educational support for this initiative is provided by Novo Nordisk. Click here to learn more: https://learn.acc.org/Page/learnHSCRP

Related References

Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 2017;23:464-75).

Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646.

Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56–e528.

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC. 2019;73(24):e285-350.

Lloyd-Jones DM, Braun LT, Ndumele CE, et al. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. JACC. 2019; 73(24):3153–3167.

Ridker PM. From RESCUE to ZEUS: Will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? Cardiovasc Res. 2021;117(11):e138-e140.

Subscribe to CardiaCast

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Baggish, Levine, and Martinez to continue their deep dive into the recently released 2025 Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.

Subscribe to CardiaCast | Claim CME Credit

"Courtside with the Chair" is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Aaron Baggish, Benjamin Levine, and Matthew Martinez to take a deep dive into the recently released 2025 Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.

Subscribe to CardiaCast | Claim CME Credit

"Heart Vision" is a CardiaCast podcast series produced by the ACC Cardiovascular Imaging Section Leadership Council. This podcast series tackles topics on emerging multimodality imaging data, trends, practice patterns, disease status and advocacy effort.

In this episode, Drs. Purvi Parwani and Michael Salerno discuss how stress cardiovascular magnetic resonance (CMR) is transforming the way we understand and diagnose coronary microvascular dysfunction. We will also discuss the noninvasive comparison of the stress CMR with stress positron emission tomography (PET) for evaluation of myocardial perfusion reserve index, its clinical applications and practical usage. Dr. Salerno will shed light on how this innovative imaging technique is offering new insights into the pathophysiology of the microvasculature, guiding the diagnosis, and ultimately improving patient outcomes through the correct diagnosis.

In this podcast, which is part of the AFib Management Redefined: Latest Guidelines For Care of the Patient With Atrial Fibrillation grant initiative, Andrea Price, MS, AACC hosts Brooke Gonzales, RN, Elena Wellen PharmD, BCCP, Megan Herrington, PA-C, AACC and Meena Rao, MD, MPH, FACC in a multidisciplinary discussion highlighting the 2023 Guideline updates and the importance of a patient centered cardiac care team approach to AFib diagnosis, management, and treatment. The conversation will focus on interprofessional collaboration and how to tailor care based on individual patient characteristics and preferences.

This podcast is part of the AFib Management Redefined: Latest Guidelines For Care of the Patient With Atrial Fibrillation grant initiative. Educational grant support is provided by Abbott Laboratories, Biosense Webster, Boston Scientific Corporation, and Janssen Scientific Affairs. Click here for more: https://learn.acc.org/Page/LearnAFibGuidelines

Atrial Fibrillation Focused Update | Journal of the American College of Cardiology

2023 Atrial Fibrillation Guideline-at-a-Glance | JACC

In this episode of Conversations with Critical Care Cardiologists, we dive into the evolving landscape of education and training in Critical Care Cardiology (CCC). As this specialty rapidly advances, what cognitive competencies should be prioritized? How do procedural skills fit into the equation? And who holds the responsibility for defining and standardizing these competencies? Join us as we explore the future of CCC training, the role of medical societies, and strategies for ensuring consistency and excellence in education—both within CCC and across the broader field of cardiology.

Subscribe to CardiaCast |

"Innovation in Action" is a new podcast series hosted by the American College of Cardiology's (ACC) Innovation Program aimed to explore innovations shaping care delivery. In this first episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by Drs. Amey Vrudhula and Lily Stern to delve into artificial intelligence (AI) model training and how to leverage AI for early screening of cardiac amyloidosis.

This podcast is supported by AstraZeneca.

Related References:

Vrudhula A, Stern L, Cheng PC, et al. Impact of case and control selection on training artificial intelligence screening of cardiac amyloidosis. JACC Adv 2024;3:100998.

Subscribe to CardiaCast | Claim CME Credit

Special Edition: "PulseCheck" is a series within CardiaCast that is designed for CV Team members, offering practical team-based solutions to the everyday challenges. In this series the CV Team Section has partnered with the Geriatric Section's Palliative Care Workgroup to share insights on difficult conversations that occur when caring for cardiology patients. In this episode, Andrea Price, MS, AACC hosts S. Ian Borison, DO; Michelle Churchill, CRNP, ACHPN and Jill Steiner, MD, MS, FACC to share insights to training our trainees in skilled serious illness communication.

Subscribe to CardiaCast | Claim CME Credit

Special Edition: "PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members, offering practical team-based solutions to the everyday challenges. In this series the CV Team Section has partnered with the Geriatric Section's Palliative Workgroup to share insights on difficult conversations that occur when caring for cardiology patients. In this episode, Andrea Price, MS, AACC hosts Richard A. Josephson, MS, MD, FACC, Christy Cantey DNP, FNP-C, AACC, CCK, and Gwen M. Bernacki, MD MHSA to share insights for high-risk procedures in our high risk patients: we can, but should we?

Suggested Materials:

Vital Talk website. 2024. Available at https://www.vitaltalk.org/. Accessed 12/20/24.

The Conversation Project - Have You Had The Conversation? (Institute for Healthcare Improvement website). 2024. Available at https://theconversationproject.org/. Accessed 12/20/24.

Bernacki GW, Starks H, Krishnaswami A, et al. Peri-procedural code status for transcatheter aortic valve replacement: Absence of program policies and standard practices. J Am Geriatr Soc 2022;70:3378-89.

Subscribe to CardiaCast | Claim CME Credit

Special Edition:"PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members, offering practical team-based solutions to the everyday challenges. In this series the CV Team Section has partnered with the Geriatric Section's Palliative Workgroup to share insights on difficult conversations that occur when caring for cardiology patients. In this episode, Andrea Price, MS, AACC hosts Alex Tabone, PA-C, AACC, Alix Barnes, MD, and Sharon Dickinson, PA-C, FACC to share insights for serious conversations in the critical care trenches.

Suggested Materials:

Godfrey S, Barnes A, Gao J, Sulistio MS, Katz JN, Chuzi S. Shared Decision-making in Palliative and End-of-life Care in the Cardiac Intensive Care Unit. US Cardiology Review 2024;18:e13.

Colorado Program for Patient Centered Decisions (Patient Decision Aid website). 2024. Available at https://www.patientdecisionaid.org/. Accessed 12/20/24.

Subscribe to CardiaCast | Claim CME Credit

Special Edition: "PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members, offering practical team-based solutions to the everyday challenges. In this series the CV Team Section has partnered with the Geriatric Section's Palliative Care Workgroup to share insights on difficult conversations that occur when caring for cardiology patients. In this episode, Andrea Price, MS, AACC hosts Jae Patton, MSN, CRNP, AACC and Sarah Godfrey, MD, MPH to share insights for ensuring quality of life when time is short: tools for the end-stage heart failure care.

Suggested Materials

Center to Advance Palliative Care (Center to Advance Palliative Care website). 2024. Available at https://www.capc.org/. Accessed 12/20/24.

Godfrey S, Kirkpatrick JN, Kramer DB, Sulistio MS. Expanding the paradigm for cardiovascular palliative care. Circulation 2023;148:1039-52.

Godfrey S, Chen CL, Sulistio MS, Kumar S, Newcomer K. Shocked at end-of-life: an educational video for hospice workers about implantable cardioverter-defibrillators. J Pain Symptom Manage 2024;67:e557-58.

Subscribe to CardiaCast | Claim CME Credit

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Peter Dean, Keri Shafer, and Jonathan Edelson to discuss the emergence of Pediatric Sports Cardiology. Dr. Kim moderates the discussion about important issues within pediatric sports cardiology that differentiates from the clinical thinking around adult athletes. The conversation over two parts focuses on the need for the field of pediatric sports cardiology, what defines a 'pediatric athlete', considerations for screening this population, differences with shared decision-making compared to adult athletes, and gaps in knowledge.

Subscribe to CardiaCast | Claim CME Credit

"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Peter Dean, Keri Shafer, and Jonathan Edelson to discuss the emergence of Pediatric Sports Cardiology. Dr. Kim moderates the discussion about important issues within pediatric sports cardiology that differentiates from the clinical thinking around adult athletes. The conversation over two parts focuses on the need for the field of pediatric sports cardiology, what defines a 'pediatric athlete', considerations for screening this population, differences with shared decision-making compared to adult athletes, and gaps in knowledge.

Subscribe to CardiaCast | Claim CME Credit

Echocardiography (Echo) and point-of-care ultrasound (POCUS) play a critical role in the cardiac intensive Care Unit (CICU). In this episode, our expert cardiologists Drs. Rosy Thachil, Shashank Sinha, Smadar Kort and Eugene Yuriditsky examine the latest advancements, techniques, and clinical applications of Echo and POCUS in managing critically ill cardiac patients. Learn how these powerful imaging tools can enhance diagnostic accuracy, provide real-time data, guide therapeutic interventions, and improve patient outcomes in the high-stakes environment of the CICU. Whether you're a seasoned cardiologist or a healthcare professional new to critical care cardiology, there is much to learn from these valuable insights and practical tips for optimizing the use of Echo and POCUS.

Related References:

Kirkpatrick JN, Grimm R, Johri AM, et al. Recommendations for echocardiography laboratories participating in cardiac point of care cardiac ultrasound (POCUS) and critical care echocardiography training: report from the American Society of Echocardiography. J Am Soc Echocardiogr 2020;33:409-422.e4.

Subscribe to CardiaCast |

Special Edition: PharmD Appreciation: "PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, HF-Cert, AACC; Lydia Tran, PharmD, BCPS and Bruce Warden, PharmD, BCPS, FNLA, FASPC to discuss the role of the pharmacists of the care team for lipid management.

Subscribe to CardiaCast

Special Edition: PharmD Appreciation: "PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Lydia Tran, PharmD, BCPS and Sushma Dey, PharmD, BCACP to discuss the role of the pharmacists on the care team for hypertension management.

Subscribe to CardiaCast

In this installment of Atrial Fibrillation (AFib) and Antiarrhythmic Drugs (AADs) series, Dr. Suneet Mittal interviews Dr. Jeff Healey about evidence supporting the guidelines and how they compare to previous guidelines. Listen as Dr. Healey analyzes the utilization of AADs based on the 2023 guidelines.

This podcast is part of Early Onset of Atrial Fibrillation & the Contemporary Use of Antiarrhythmic Drugs grant initiative.

Educational grant support is provided by Sanofi. Click here for more: https://learn.acc.org/Page/LearnAntiarrhythmicDrugsforAF

Subscribe to CardiaCast | Claim CME Credit

Special Edition: PharmD Appreciation: "PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members are new, or new to cardiology, offering practical team-based solutions to the everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific Pharmacist focus. In this episode, Andrea Price, MS, AACC hosts Anastasia Armbruster, PharmD, FACC, BCCP and Megan Labreck, PharmD, BCPS, CACP to discuss the most recent atrial fibrillation (Afib) guidelines and what the documents mean to a pharmacist working on a cardiac arrhythmia care team.

Subscribe to CardiaCast

In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Michelle Kittleson recommendations for early diagnosis in the 2024 HCM guideline and review the latest clinical and real-world trial data for new (mavacamten) and emerging (aficamten) cardiac myosin inhibitors.

This CardiaCast is part of an educational series, "2024 Update to the AHA/ACC HCM Guideline: Expert Interpretation for Application to Practice," which includes a total of three ACC CardiaCasts and an accredited #MedX. The series is produced by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bristol Myers Squibb. Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors (acc.org)

Suggested Materials:

Olivotto I, Oreziak A, Barriales-Villa R, et al; EXPLORER-HCM study investigators. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2020;396:759-69. Erratum in: Lancet 2020;396:758.

Desai MY, Owens A, Wolski K, et al. Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 56 results from the VALOR-HCM randomized clinical trial. JAMA Cardiol 2023;8:968-77.

Maron MS, Masri A, Nassif ME, et al; SEQUOIA-HCM Investigators. Aficamten for symptomatic obstructive hypertrophic cardiomyopathy. N Engl J Med 2024;390:1849-61.

Special Edition: PharmD Appreciation: "PulseCheck" is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to everyday challenges. This series, published during American Pharmacists Month, celebrates our pharmacist CV Team members in an educational series with a specific PharmD focus. In this episode, Andrea Price, MS, AACC hosts Jessie Dunne, PharmD, BCCP, BCPC and Orly Vardeny, PharmD, MS, FAHA, FHFSA to discuss the most recent heart failure guidelines, expert consensus publication, and what these documents mean to a pharmacist working on a heart failure care team.

Subscribe to CardiaCast

In this episode of CardiaCast, hypertrophic cardiomyopathy (HCM) expert Dr. Matthew Martinez will discuss with Dr. Cesar Herrera challenges that exist in Latin America related to the application of the recently issued guideline, "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines."

This CardiaCast is part of an educational series, "2024 Update to the AHA/ACC HCM Guideline: Expert Interpretation for Application to Practice," which includes a total of three ACC CardiaCasts and an accredited #MedX. The series is produced by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bristol Myers Squibb. Exploring HCM Diagnosis and Treatment Options: The New Frontier of Cardiac Myosin Inhibitors (acc.org)

Subscribe to CardiaCast

"PulseCheck" is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This series, published during Peripheral Artery Disease (PAD) Awareness Month, is in collaboration with the ACC's Vascular Disease Section. In this episode, Andrea Price, MS, AACC hosts Demetria Bolden, PhD, MBA, CPTD, Osama Ibrahim, MD, FACC and Bailey Estes, MSN, AGNP-C for the final installment of the PAD series focused on the impact of social determinants of health for the PAD patient population.

Subscribe to CardiaCast

"PulseCheck" is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This series, published during Peripheral Artery Disease (PAD) Awareness Month, is in collaboration with the ACC's Vascular Disease Section. In this episode, Andrea Price, MS, AACC hosts Craig Beavers, BCCP, BCPS-AQ, FACC, Maya Serhal MD, FACC and Bailey Estes MSN, AGNP-C for a discussion on guideline directed medical therapy (GDMT) and supervised exercise therapy in the treatment of PAD.

Subscribe to CardiaCast

"PulseCheck" is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This series, published during Peripheral Artery Disease (PAD) Awareness Month, is in collaboration with the ACC's Vascular Disease Section. In this episode, Andrea Price, MS, AACC hosts Derek Pineda, NP, AACC, Bailey Estes, MSN, AGNP-C, and Pradeep Nair, MD, FACC for a discussion of interventional treatment options for PAD.

Subscribe to CardiaCast

PulseCheck" is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This series, published during Peripheral Artery Disease (PAD) Awareness Month, is in collaboration with the ACC's Vascular Disease Section. In this episode, Andrea Price, MS, AACC hosts Hussein Abu Daya MD, FACC, Brian Rose, PA-C, MPH, AACC and Bailey Estes MSN, AGNP-C, to begin the PAD series with an introductory overview.

"Courtside with the Chair" is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this "Part 2" episode, Dr. Jonathan Kim continues the conversation with Drs. Michael Ackerman, Rachel Lampert, and Matthew Martinez of the "how to" and approach to shared decision-making in the context of sports participation for athletes with heart disease.

Suggested Materials: (You can include formal references external to ACC.org here. Please list numerically as formal citations. Example: Cannon JA, Moffitt P, Perez-Moreno AC, et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 2017;23:464-75).

Subscribe to CardiaCast | Claim CME Credit

In this episode, Drs. Erin Michos and Steven Nissen discuss newly emerging therapies for elevated Lp(a) management and forthcoming developments in research. Drs. Michos and Nissen highlight the key differences between therapies in late trial stages and discuss upcoming cardiovascular outcome trials.

This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here!

Suggested Materials:

Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): actionable strategies for risk assessment and mitigation. Am J Prev Cardiol. 2024;18:100651.

Tsimikas S, Fazio S, Ferdinand KC, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol 2018;71:177-92.

Reyes-Soffer G, Ginsberg HN, Berglund L, et al; on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. ArteriosclerThromband Vasc Biol 2022;42:e48-e60.

Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol 2024;18:e308-e319.

Subscribe to CardiaCast | More information on Elevating Lp(a) HERE

"Courtside with the Chair" is a new series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology. In this episode, Dr. Jonathan Kim is joined by Drs. Michael Ackerman, Rachel Lampert, and Matthew Martinez to discuss the "why" and "how to" related to shared decision-making in the context of sports participation for athletes with heart disease.

Subscribe to CardiaCast | Claim CME Credit

"PulseCheck" is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges that nurses and allied health professionals face every day. This episode is an update to the March 2024 PulseCheck: Shared Decision Making podcast in which host Andrea Price MS, AACC brings together Liz Perpetua ARNP, ACNP-BC, DNP, FACC, Martha Gulati MD, MS, FACC, and Bailey Estes MSN, AGNP-C, to explore best practices related to structural heart disease. Dr. Perpetua, the chair and lead author of JACC Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care, offers insights from the July 2024 publication.

Subscribe on iTunes | Subscribe on Google Play |

In this episode, Drs. Erin Michos and Gissette Reyes-Soffer discuss how clinicians can manage elevated Lp(a) by treating all modifiable factors in patients. The global risk assessment of patients and what can be done now to navigate and mitigate risk is also addressed.

This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here!

Suggested Materials:

Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): actionable strategies for risk assessment and mitigation. Am J Prev Cardiol 2024;18:100651.

Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. J Am Coll Cardiol 2018;71:177-92.

Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al; on behalf of the American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 2022;42:e48-e60.

Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol 2024;Mar 29:[ePub ahead of print].

Subscribe to CardiaCast | More information on Elevating Lp(a) HERE

In this episode, Drs. Erin Michos and Christie Ballantyne examine the importance of testing and identifying lipoprotein(a) ( Lp[a]) levels in patients, research highlighting trends in populations at risk, and the genetic factors involved in assessment. The significance associated with various levels of Lp(a) in measurement and how testing plays a role in management is also discussed.

This CardiaCast episode is part of an ACC course titled Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap. Educational grant support is provided by Novartis. To visit the Online Course page for the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap Grant, click here!